, Indonesia
Photo courtesy of Lexasure Financial Group

Lexasure partners up with Blimobil for wider insurance offerings

Lexasure will make an investment in Blimobil.

Lexasure Financial Group Limited and PT Nawa Carciege Indonesia (Blimobil) signed a memorandum of understanding (MoU) for a proposed strategic partnership which aims to expand their insurance products in Indonesia.

Provider of reinsurance and insurtech in South and Southeast Asia, Lexasure, will invest in the Indonesian auto market digital trading platform, Blimobil.

“[Both parties] will offer access to insurance products, including car insurance, usage-based auto insurance, home appliance, auto extended warranty insurance, and guaranteed asset protection (GAP) insurance,” Lexasure stated.

Other than the new and diversified insurance offerings, back-end digital onboarding solutions and claims management will also be provided by Lexasure.

This will be applicable toward reinsurance capabilities such as personal cybersecurity insurance, personal accident, electronic products, extended warranty, pet insurance, and other lifestyle insurance.

“The creation of the proposed strategic partnership is subject to the negotiation of definitive agreements with customary closing conditions, including regulatory approval,” Lexasure said.

 

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.